Throughout the 1990s, Amgen continued in the same vein, investing heavily in R&,D, expanding its sales and bringing out new medications such as Infergen, an anti-hepatitis C medication ...
HYDERABAD, India (Reuters) - U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback